{"id":"etebenecid","rwe":[],"tags":[{"label":"etebenecid","category":"class"},{"label":"Small Molecule","category":"modality"},{"label":"Active","category":"status"}],"phase":"phase_2","safety":{},"trials":[],"aliases":[],"patents":[],"pricing":[],"allNames":"ethebenecid","offLabel":[],"synonyms":["ethebenecid","etebenecid","ethebenecide"],"timeline":[],"approvals":[],"brandName":"Ethebenecid","ecosystem":[],"mechanism":{"modality":"Small Molecule","drugClass":"etebenecid","explanation":"Imagine your cells have special doors that let certain things in and out. Ethebenecid blocks these doors, preventing certain substances from entering or leaving the cell. This can affect how the cell works and responds to its environment.","oneSentence":"Ethebenecid is thought to work by inhibiting the transport of certain substances across cell membranes.","technicalDetail":"Ethebenecid is believed to act as a competitive inhibitor of organic anion transporters, specifically OAT1 and OAT3, which play a crucial role in the renal excretion of various endogenous and exogenous compounds."},"commercial":{},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/1079","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=ETEBENECID","fields":["publications"],"source":"PubMed/NCBI"}],"_enrichedAt":"2026-03-30T11:14:50.406097","biosimilars":[],"competitors":[],"genericName":"etebenecid","indications":{"approved":[],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[],"trialDetails":[],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"crossReferences":{"UNII":"4413I5098G","CHEBI":"CHEBI:135060","INN_ID":"1164","UMLSCUI":"C1880566","ChEMBL_ID":"CHEMBL1705586","PUBCHEM_CID":"14604"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[],"publicationCount":0,"therapeuticAreas":["Nephrology"],"biosimilarFilings":[],"recentPublications":[],"companionDiagnostics":[],"genericManufacturerList":[],"status":"active","companyName":"","companyId":"","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Ethebenecid is a small molecule drug in the etebenecid class, but specific details about its development, commercial status, and approved indications are not available. As a result, there is limited information about its target, pharmacokinetics, and safety profile. Further research is needed to understand the clinical utility and potential risks associated with etebenecid. The exact mechanism of action and approved uses of etebenecid are currently unknown. It is essential to consult reliable sources for accurate information about this drug.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":false,"score":1}}